elsunersen
Nucleic acidexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Feb 28, 2023 (NCT05737784)
Timeline
Indications
Mechanism of action
- ScN2aANTISENSE INHIBITOR
ScN2a antisense inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL6068116 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07019922 | Phase 3 | Aug 13, 2025 | Praxis Biologics |
| NCT05737784 | Phase 1/Phase 2 (Phase 2) | Feb 28, 2023 | Praxis Biologics |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Praxis Biologics | For profit | 2 | 2 | 2 | 2023 |
1 organizations
Page 1 / 1